TOI stockholders elect all eight director nominees, ratify auditor, approve say-on-pay at 2026 annual meeting

Oncology Institute, Inc.

Elected eight directors: Brad Hively, Karen Johnson, Mohit Kaushal, Anne McGeorge, Mark Pacala, Mark Stolper, Kimberly Tzoumakas, Daniel Virnich.
Ratified BDO USA, P.C. as independent auditor for FY 2026 with 75,098,890 votes for, 37,257 against.
Say-on-pay approved with 25,280,934 for, 282,655 against, 12,126 abstain.
Advisory vote on executive compensation frequency: annual preferred with 24,918,766 votes (1-year).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Oncology Institute, Inc. shareholders approved Approval, on a non-binding, advisory basis, of the preferred frequency of future advisory votes on the compensation of the Company’s named executive officers (the “Say-on-Frequency Proposal”) at the 2026-06-17 meeting.

Proposal: say on pay frequency
Outcome: passed
Meeting: 2026-06-17

Exact text from the filing

The Say-on-Frequency Proposal was approved

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Oncology Institute, Inc. shareholders approved Approval, on a non-binding, advisory basis, of the Company’s named executive officers (the “Say-on-Pay Proposal”) at the 2026-06-17 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-17

Exact text from the filing

The Say-on-Pay Proposal was approved.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Oncology Institute, Inc. shareholders approved Election of eight directors at the 2026-06-17 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-17

Exact text from the filing

The Company’s stockholders elected eight directors to serve for the ensuing year and until their successors are elected and qualified, or until their earlier death, resignation or removal.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Oncology Institute, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accountants at the 2026-06-17 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-17

Exact text from the filing

The ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved.

View on SEC.gov

1183 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Oncology Institute, Inc. filing history →

Source: SEC EDGAR

accession 0001553350-26-000093

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.